Quick Answer: L. crispatus is the dominant protective vaginal bacterium for many women - higher crispatus abundance associates with lower BV recurrence risk, while L. iners is common yet less protective alone.
What Should You Know About Vaginal Lactobacillus Species?
The healthy vaginal microbiome is not one monolithic thing - it varies considerably between women. For a broader primer, start with our vaginal microbiome 101 hub. Many healthy microbiomes are dominated by Lactobacillus species that produce lactic acid and keep vaginal pH low, but not all: in a study of 396 healthy women, one of the five community types found had fewer lactobacilli and more anaerobes, and average vaginal pH differed between ethnic groups.1 Which Lactobacillus species dominates also appears to matter.
DNA sequencing has changed how researchers study vaginal bacteria, showing that vaginal microbiome composition varies between women and can shift over days to weeks.2 It also suggested that some Lactobacillus species are associated with more stable communities than others.
Not all Lactobacillus species appear equally protective: communities dominated by L. crispatus are generally associated with greater stability and lower BV risk than those dominated by L. iners, although most of this evidence is observational, and the absence of Lactobacillus dominance does not by itself mean disease.3
Why Is L. Crispatus Called the Gold Standard of Vaginal Protection?
Prevalence and Natural Distribution
L. crispatus is one of the most common dominant species in reproductive-age women, but how common it is varies between populations and ethnic groups.1 For how these products are labeled and what to check on the panel before buying, see our lactobacillus crispatus supplement guide.
Women with L. crispatus dominance (≥50% of total vaginal bacteria) have distinctly different infection profiles than women without. Observational studies associate L. crispatus dominance with lower bacterial vaginosis (BV) risk; links to yeast and urinary tract infections are less clear.
Lactic Acid Production: The Primary Protective Mechanism
L. crispatus produces large amounts of lactic acid, including both the D- and L- forms, while L. iners produces mainly the L- form. Lactic acid at the low pH of a Lactobacillus-dominated vagina is a potent microbicide in laboratory measurements (PMID: 24223212), which is one reason researchers think L. crispatus communities are more protective.
Additional Protective Mechanisms
Beyond lactic acid production, L. crispatus provides protection through:
Bacteriocin Production: L. crispatus produces bacteriocins, a class of natural antimicrobial peptides. Bacteriocins are understood to act on the cell membranes of competing bacteria, and that competitive pressure is part of how lactobacilli are thought to shape which organisms dominate a vaginal community. This is mechanism-level biology rather than a measured clinical outcome.
Epithelial Adhesion: L. crispatus can adhere to vaginal epithelial cells, which may limit the space available to other bacteria.
Hydrogen Peroxide Production: Some L. crispatus strains produce hydrogen peroxide, which has antimicrobial properties. However, this is a minor mechanism compared to lactic acid and bacteriocins.
Immunomodulation: L. crispatus interacts with the immune system of the vaginal lining; how much this contributes to protection is still being studied.
Note: Most of these mechanisms come from laboratory and observational studies. They help explain why L. crispatus communities are associated with lower BV risk, but they do not prove that adding L. crispatus prevents infection.
Why Is L. Iners Common Yet Less Protective on Its Own?
What Is L. Iners?
L. iners dominates the vaginal community in a substantial share of healthy women.1 However, recent research has fundamentally changed our understanding of L. iners's protective value - and it's not as reassuring as clinicians once thought.
L. iners produces predominantly L-lactic acid (not the protective D-lactic acid produced by L. crispatus). This L-lactic acid can be metabolized by BV-associated bacteria, providing minimal protection against dysbiosis. Communities dominated by L. iners appear more likely to shift toward BV than L. crispatus-dominated ones.
Why L. Iners Is Different
Researchers are still working out whether L. iners-dominated communities are less stable because of L. iners itself or because of other factors that travel with it.
When L. Iners Is Fine
L. iners is not "bad", and many women with L. iners-dominated communities have no symptoms. Symptoms, not a species name on a test report, are what call for a clinician's assessment.
Other Important Vaginal Lactobacillus Species
L. Gasseri: The Secondary Protector
L. gasseri is another species that can dominate a healthy vaginal community.1 Evidence that it protects against particular infections is limited.
L. Jensenii: The Supporting Player
L. jensenii can also dominate a healthy vaginal community.1 It is less studied than L. crispatus.
Other Vaginal Lactobacillus Species
Several other lactobacillus species are occasionally found in vaginas but contribute minimally to protection:
L. vaginalis: Found in some women, produces some lactic acid but minimal research on protective function
L. delbrueckii: Rare in healthy vaginas, minimal protection data
L. reuteri: Not a typical dominant vaginal species; some strains have been studied orally together with L. rhamnosus GR-1
L. rhamnosus: A well-studied oral probiotic species; taken orally with RC-14, the GR-1 strain increased vaginal lactobacilli compared with placebo, but it is not a typical dominant vaginal species and has not been shown to prevent UTIs
L. plantarum: Not a typical dominant vaginal species; one strain has been studied as a vaginal capsule after yeast infection treatment
How Do the Species Compare?
Researchers have not established a precise ranking. Broadly, observational studies associate L. crispatus dominance with the most stable communities and the lowest BV risk, L. gasseri and L. jensenii dominance with stable but less studied communities, L. iners dominance with more frequent shifts toward BV, and communities with few lactobacilli with the highest BV risk.3 Individual risk also depends on sexual practices, hormones, smoking and other factors.
How to Establish L. Crispatus Dominance
Why Some Women Lack L. Crispatus
Many women do not have L. crispatus as their dominant vaginal species. This variation appears to be a combination of genetic factors (vaginal epithelial characteristics that favor certain species), environmental factors (antibiotic history, sexual partners), and behavioral factors (douching, product use, stress, sleep). Whether supplementation can establish lasting L. crispatus dominance is still being studied.
L. Crispatus Probiotic Supplementation
The strongest trial is Lactin-V, a vaginally delivered L. crispatus CTV-05 product used after metronidazole gel: BV recurred by week 12 in 30% of women on Lactin-V versus 45% on placebo (PMID: 32402161), and the strain was detected in 79% of users at week 12 (PMID: 32402161). Lactin-V is an investigational live biotherapeutic, not a retail supplement.
It's worth noting that most probiotic supplements do not contain L. crispatus. Balance Complex does not: it contains L. acidophilus, L. rhamnosus, L. reuteri, L. plantarum, and Bacillus coagulans, taken orally, and none of these is a typical dominant vaginal species or a substitute for L. crispatus.
Supporting Factors for L. Crispatus Establishment
Several habits are associated with a healthier vaginal microbiome, although none has been shown to establish L. crispatus specifically:
Avoid douching: Douching disrupts all vaginal bacteria, undermining L. crispatus establishment
Use pH-balanced cleansers only: Avoid scented products and regular soaps
Avoid smoking: Smoking is associated with BV
Sleep, stress and diet: Good general habits, though their effect on vaginal species is not established
Want to know which vaginal lactobacillus species you have? A vaginal microbiome test uses PCR or DNA sequencing to identify your dominant species, and your clinician can order a panel if at-home collection is not available in your region.
Conclusion: Why Species Matters
L. crispatus-dominated communities are associated with lower BV risk than L. iners-dominated or low-Lactobacillus communities, although most of the evidence is observational.3 The best trial evidence for adding L. crispatus comes from a vaginally delivered investigational product used after antibiotics (PMID: 32402161), which is a different category from oral supplements.
Understanding species differences helps you read labels and research critically: a product's species, strain and delivery route should match the evidence it relies on, and recurrent symptoms still call for a clinician.
References
- Ravel J et al., 2011. PMID: 20534435
- Gajer et al., 2012. PMID: 22553250
- Petrova et al., 2015. PMID: 25859220
- Cited study. PMID: 24223212
- Cited study. PMID: 32402161